Table 1 Baseline Characteristics MRS ≤ 2
Variable | Bridging | Non-Bridging | p-value |
|---|---|---|---|
(n = 103) | (n = 63) | ||
Sex (n, %) | 0.29 | ||
Male | 55 (53.4) | 39 (61.9) | |
Female | 48 (46.6) | 24 (38.1) | |
Age (mean ± SD) | 67 (±14.28) | 69 (±11.18) | 0.29 |
Vasc. risk-factors (n, %) | |||
Art. hypertension | 69 (67) | 45 (71.4) | 0.55 |
Smoking | 27 (27.3) | 23 (37.1) | 0.19 |
Diabetes | 17 (16.5) | 14 (22.2) | 0.36 |
Dyslipidemia | 39 (37.9) | 23 (36.5) | 0.86 |
Atrial fibrillation | 25 (24.3) | 21 (33.3) | 0.21 |
Baseline medication (n, %) | |||
Aspirin | 28 (28.9) | 12 (20) | 0.22 |
Clopidogrel | 3 (3.1) | 2 (3.3) | 0.93 |
Anticoagulation | 0 (0) | 18 (28.6) | < 0.001 |
NIHSS at admission (median points, IQR) | 12 (7–16) | 10 (5–15) | 0.14 |
Symptom-onset to admission (median time, IQR) | 69 (40–171) | 205 (73–508) | < 0.001 |
ASPECTS (median points, IQR) | 9 (8–10) | 8 (7–10) | 0.01 |
General anesthesia (n, %) | 68 (66) | 41 (65) | 0.16 |
Treatment adverse event (n, %) | 12 (11) | 8 (12) | 0.72 |
NIHSS at discharge (median points, IQR) | 2 (0–4) | 2 (1–3) | 0.24 |
mTICI ≥2b after EVT (n, %) | 98 (95) | 60 (95) | 0.65 |
Stroke etiology (n, %) | |||
Large-artery atherosclerosis | 22 (21) | 16 (25) | 0.57 |
Cardioembolism | 37 (36) | 27 (43) | 0.41 |
Small-vessel occlusion | 0 (0) | 1 (1) | 0.38 |
Stroke of other determined etiology | 9 (9) | 2 (3) | 0.21 |
Stroke of undetermined etiology | 23 (22) | 15 (24) | 0.85 |
Stroke localization (n, %) | |||
Right hemispheric stroke | 56 (54) | 29 (46) | 0.44 |
Left hemispheric stroke | 34 (33) | 27 (43) | 0.44 |
Vertebrobasilar stroke | 13 (13) | 7 (11) | 0.99 |
A. cerebri anterior | 1 (1) | 0 (0) | 0.99 |
A. cerebri media M1 proximal | 33 (32) | 28 (44) | 0.14 |
A. cerebri media M1 distal | 26 (25) | 14 (22) | 0.71 |
A. cerebri media M2 | 23 (22) | 13 (21) | 0.85 |
A. carotis interna T | 10 (10) | 5 (8) | 0.79 |
A. carotis interna extracranial | 2 (2) | 2 (3) | 0.64 |